UNSPSC 51192200: Combination diuretics

This classification denotes combination drugs and preparations that promote excretion of urine by influencing human kidney function, commonly known as DIURETICS. The major diuretic types include osmotic (diuretics that increase urine volume by increasing osmotically-active urine solute); potassium sparing (diuretics that limit potassium secretion in urine); sodium chloride symporter inhibitors; and sodium potassium chloride symporter inhibitors.

Diuretics, that is, operate by stimulating he nervous system, by alleviating kidney congestion, by increasing blood pressure, or by increasing or improving liquid transport. Typical combination diuretic constituents are hydrochlorothiazide, potassium chloride, spironolactone, and triamterene.

UNSPSC 51192200 Combination diuretics is a Class code, but the recent state and local opportunities tagged under it reflect substantial category mismatch — the code nominally covers pharmaceutical diuretics, yet the three most recent solicitations procure industrial valve maintenance services, parenteral pharmaceutical products and delivery, and sodium bisulfite chemical supply for water treatment. The code shows no recent activity actually aligned with combination diuretics procurement by state or local governments. Broward County, Florida's RFI for DeZurik/APCO wastewater valves and repair services, the Washington State Department of Corrections' RFQQ for parenteral nutrition solutions and intravenous products, and the City of Meriden's IFB for sodium bisulfite represent distinct commodity families — none are diuretic pharmaceuticals. The lack of relevant recent opportunities under this code suggests either sparse demand for combination diuretics by state and local health systems, prison health programs, or other public bodies, or systematic misclassification during intake.

No recent state or local procurement activity for combination diuretics themselves is visible in the source data. Organizations evaluating this code for business development should treat it as inactive for near-term pursuit and investigate whether state and local pharmacy buyers, correctional health programs, or public health agencies use alternate UNSPSC classifications for diuretic procurements, or whether diuretic purchasing flows through group purchasing organizations, GPOs, or master service agreements negotiated at the state or federal level rather than through individual jurisdictional solicitations.